ARCHIVES

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.

December 19, 2008

In Brief: Groups agree On Mammography Screening: Money Bill Markups Due After July 4 Recess

June 23, 1989

DCT Advisors Approve Five Trials For High Priority Status

April 7, 1995

Farber Grant Probe Misses Real Story

July 8, 1977

ACCC Members Hear How Community Cancer Programs Are Developed

February 11, 1977

DCT Advisors Approve Increased Spending On Trials Monitoring

May 6, 1994